An association between serum basic fibroblast growth factor (bFGF) and Bcl-2 in patients with chronic lymphocytic leukemia.

被引：0
|
作者：
Bairey, O
Zimra, Y
Rabizadeh, E
Shaklai, M
机构：
[1] Rabin Med Ctr, Inst Hematol, Petah Tiqwa, Israel
[2] Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4536
引用
收藏
页码：294B / 294B
页数：1
相关论文
共 50 条
  • [1] Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia
    Bairey, O
    Zimra, Y
    Shaklai, M
    Rabizadeh, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 400 - 406
  • [2] Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis
    Konig, A
    Menzel, T
    Lynen, S
    Wrazel, L
    Rosen, A
    AlKatib, A
    Raveche, E
    Gabrilove, JL
    LEUKEMIA, 1997, 11 (02) : 258 - 265
  • [3] Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis
    A König
    T Menzel
    S Lynen
    L Wrazel
    A Rosén
    A Al-Katib
    E Raveche
    JL Gabrilove
    Leukemia, 1997, 11 : 258 - 265
  • [4] Bcl-2 expression correlates negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukemia.
    Bairey, O
    Zimra, Y
    Rabizadeh, E
    Shaklai, M
    BLOOD, 2000, 96 (11) : 269B - 269B
  • [5] Prognostic significance of bcl-2 expression in chronic lymphocytic leukemia.
    Mapara, MY
    Bommert, K
    Bargou, R
    Daniel, PT
    Stilgenbauer, S
    Benner, A
    Lichter, P
    Dorken, B
    Dohner, H
    BLOOD, 1997, 90 (10) : 398 - 398
  • [6] Serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in children with acute lymphoblastic leukemia.
    Palgan, L
    Wysocki, M
    Palgan, K
    Debski, R
    Odrowaz-Sypniewska, G
    Styczynski, J
    BLOOD, 2004, 104 (11) : 180B - 181B
  • [7] Bcl-2 family gene expression and Bcl-2 phopshorylation status in chronic lymphocytic leukemia.
    Viswanathan, S
    Saxena, A
    FASEB JOURNAL, 1998, 12 (05): : A810 - A810
  • [8] Bcl-2 antisense (Genasense) as monotherpay for refractory chronic lymphocytic leukemia.
    O'Brien, S
    Giles, F
    Rai, K
    Andreeff, N
    Cunningham, C
    Frankel, S
    Keating, M
    BLOOD, 2001, 98 (11) : 772A - 772A
  • [9] Basic fibroblast growth factor (bFGF) up-regulates expression of BCL-2 in chronic lymphoid leukemia cell lines resulting in delayed apoptosis.
    Konig, A
    Menzel, T
    Calleja, E
    Gencarelli, A
    Gabrilove, J
    BLOOD, 1995, 86 (10) : 3334 - 3334
  • [10] SPC2996 - A Bcl-2 inhibitor for treatment of chronic lymphocytic leukemia.
    Hansen, B
    Westergaard, M
    Frieden, M
    Hansen, HF
    Thrue, CA
    Kjaerulff, LS
    Koch, T
    Kearney, P
    Oerum, H
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8975S - 8975S
12345